Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy.

Seikkula, Heikki; Syvänen, Kari T; Kurki, Samu; Mirtti, Tuomas; Taimen, Pekka; Laato, Matti; Boström, Peter J

Seikkula, Heikki; Syvänen, Kari T; Kurki, Samu; Mirtti, Tuomas; Taimen, Pekka; Laato, Matti; Boström, Peter J.

Afiliación

Seikkula H; Department of Urology, Turku University Hospital, Turku, Finland. Electronic address: heikki.seikkula@tyks.fi.
Syvänen KT; Department of Urology, Turku University Hospital, Turku, Finland.
Kurki S; Auria Biobank, Turku University Hospital, Turku, Finland.
Mirtti T; Department of Pathology (HUSLAB), Helsinki University Hospital, and Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
Taimen P; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland.
Laato M; Department of Urology, Turku University Hospital, Turku, Finland.
Boström PJ; Department of Urology, Turku University Hospital, Turku, Finland.

Urol Oncol ; 33(1): 16.e1-16.e7, 2015 Jan.

Article en En | MEDLINE | ID: mdl-25456996

Palabras clave

PSA doubling time; Prostate cancer; Radical prostatectomy; Ultrasensitive PSA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google